CAS MEDICAL SYSTEMS, INC. (NASDAQ:CASM) Files An 8-K Submission of Matters to a Vote of Security HoldersItem 5.07
Submission of Matters to a Vote of Security Holders.
CAS MEDICAL SYSTEMS, INC. (NASDAQ:CASM) Files An 8-K Submission of Matters to a Vote of Security Holders
At the annual meeting of stockholders of CAS Medical Systems, Inc. (the "Company") held on June 20, 2018, four proposals were voted upon and approved by the Company's stockholders. A brief description of each proposal voted upon at the annual meeting and the number of votes cast for, against, and withheld, as well as the number of abstentions and broker non-votes, where applicable, are set forth below.
(1) Election of seven members of the Board of Directors, each for a term of one year:
|
Nominee |
For |
Withheld |
Broker Non-Votes |
|
Alan W. Milinazzo |
19,006,691 |
485,294 |
10,903,543 |
|
Paul A. Molloy |
19,005,616 |
486,369 |
10,903,543 |
|
Thomas M. Patton |
18,971,689 |
520,296 |
10,903,543 |
|
Gregory P. Rainey |
19,003,691 |
488,294 |
10,903,543 |
|
James E. Thomas |
18,993,316 |
498,669 |
10,903,543 |
|
Kathleen A. Tune |
19,005,591 |
486,394 |
10,903,543 |
|
Kenneth R. Weisshaar |
19,003,716 |
488,269 |
10,903,543 |
(2) Approval of the 2018 Equity Incentive Plan:
|
For |
Against |
Abstain |
Broker Non-Votes |
|
18,805,901 |
677,802 |
8,282 |
10,903,543 |
(3) Advisory approval of the compensation of the Company's named executive officers:
|
For |
Against |
Abstain |
Broker Non-Votes |
|
18,879,162 |
604,630 |
8,193 |
10,903,543 |
(4) Ratification of the appointment of CohnReznick LLPas auditor for the Company for the fiscal year ending December 31, 2018:
|
For |
Against |
Abstain |
|
29,509,304 |
223,431 |
662,793 |
About CAS MEDICAL SYSTEMS, INC. (NASDAQ:CASM)
CAS Medical Systems, Inc. is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products for patient care. The Company designs, manufactures and distributes the FORE-SIGHT and FORE-SIGHT ELITE brand tissue oximeters and sensors. It also sells various legacy products called Traditional Monitoring, which includes non-invasive blood pressure measurement technologies, neonatal medical disposables and service sales. It operates through two categories of sales: Tissue Oximetry Monitoring, which includes sales of its FORE-SIGHT tissue oximeter monitors, sensors and accessories, and Traditional Monitoring, which includes sales of its legacy products comprising the original equipment manufacturer (OEM) sales of its non-invasive blood pressure technology (MAXNIBP and MAXIQ), and monitor service and repair. The FORE-SIGHT Tissue Oximeter technology provides clinicians a non-invasive, quantitative measurement of oxygenation in cerebral tissue.